Chelsea Counsel Company’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$88.9K Sell
1,845
-65
-3% -$3.03K 0.04% 113
2025
Q4
$92.6K Sell
1,910
-11,835
-86% -$587K 0.04% 111
2025
Q3
$649K Sell
13,745
-500
-4% -$24.1K 0.29% 60
2025
Q2
$688K Sell
14,245
-465
-3% -$23.8K 0.34% 51
2025
Q1
$816K Sell
14,710
-125
-0.8% -$6.77K 0.44% 45
2024
Q4
$715K Sell
14,835
-1,025
-6% -$52.1K 0.37% 51
2024
Q3
$914K Sell
15,860
-50
-0.3% -$2.7K 0.45% 46
2024
Q2
$772K Buy
+15,910
New +$767K 0.39% 51
2014
Q4
Sell
-3,750
Closed -$212K 140
2014
Q3
$212K Buy
+3,750
New +$201K 0.04% 128
2014
Q2
Sell
-3,850
Closed -$201K 131
2014
Q1
$201K Hold
3,850
0.04% 119
2013
Q4
$206K Sell
3,850
-560
-13% -$28.9K 0.05% 108
2013
Q3
$223K Hold
4,410
0.05% 106
2013
Q2
$227K Buy
+4,410
New +$235K 0.06% 93

Other funds holding SNY

Chelsea Counsel Company's SNY Position: Q1 2026 in Review

Chelsea Counsel Company reduced its Sanofi (SNY) stake by 3.4% in Q1 2026, selling an estimated $3.03K and leaving 1,845 shares worth $88.9K. The position accounts for 0.04% of the portfolio, ranked #113.

Chelsea Counsel Company first reported a position in SNY in Q2 2013 and has held it in 13 quarters since. The position peaked at $914K in Q3 2024. 739 funds tracked by Wall St. Rank hold SNY as of Q1 2026.

  • Chelsea Counsel Company held 1,845 shares of Sanofi worth $88.9K as of Q1 2026.
  • Chelsea Counsel Company sold 65 Sanofi shares in Q1 2026, an estimated $3.03K.
  • Sanofi made up 0.04% of Chelsea Counsel Company's portfolio in Q1 2026, its #113 holding.
  • Chelsea Counsel Company first reported a position in Sanofi in Q2 2013 and has held it in 13 quarters since.
  • Chelsea Counsel Company's Sanofi position peaked at $914K in Q3 2024.
  • 739 funds tracked by Wall St. Rank held Sanofi as of Q1 2026.

Based on Chelsea Counsel Company's 13F filing for Q1 2026, filed 24 Apr 2026.